Login / Signup

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.

Aimaz AfroughHamza HashmiDoris K HansenSurbhi SidanaChul AhnLauren C PeresDanai DimaCiara L FreemanOmar Castaneda PuglianiniMehmet H KocogluShebli AtrashPeter M VoorheesLeyla ShuneJoseph P McGuirkGary SimmonsDouglas W SborovJames A DavisGurbakhash N M N KaurAishwarya SannareddyChristopher J FerreriMahmoud R GaballaScott GoldsmithOmar NadeemShonali MidhaCharlotte B WagnerFrederick L LockeKrina K PatelJack KhouriLarry D AndersonYi Lin
Published in: Blood cancer journal (2024)
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • stem cells
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • cell therapy
  • glycemic control
  • replacement therapy